Plain-English translation of NCT05331521 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether starting treatment with a combination of lomustine and temozolomide, followed by radiation and additional chemotherapy if needed, works better than starting with radiation first, followed by chemotherapy. The study is enrolling about 406 patients with a specific type of newly diagnosed brain tumor and will track how well patients maintain their memory, thinking skills, and daily functioning over time.
Doctors want to find the best order and combination of treatments to help patients with this type of brain tumor live longer and keep their mental abilities sharp. Right now, it's not clear whether one approach is clearly better than the other, so this study will compare them directly.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two treatment groups. One group receives six cycles of chemotherapy pills (given over about 6 months), then radiation and additional chemotherapy if the tumor progresses. The other group receives radiation first (over 5-6 weeks), then chemotherapy pills, also followed by additional treatment if needed. Throughout the study, you'll have MRI scans every 3 months, brief neurological exams, cognitive (memory and thinking) tests at least once a year, and quality-of-life questionnaires. The study will track you to see how well you maintain your brain function and overall well-being.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Germany